Login / Signup
Nimrah Inam
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Decision Making
Acute Myeloid Leukemia
Top Venues
Rare tumors
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Areeba Fareed
,
Nimrah Inam
,
Fatima Faraz
Breakthrough treatment choice for Acute Myeloid Leukemia in pediatric and adult patients: Revumenib, an oral selective inhibitor of KMTA2Ar.
Rare tumors
15 (2023)